Aurora Analytica
Oslo
About Aurora Analytica
Founded in February 2023 and incorporated in January 2024, Aurora Analytica is a pioneering health technology company dedicated to optimizing the clinical trial lifecycle and accelerating the development of new treatment options. Our AI-powered platform provides strategic insights, site intelligence, and data-driven tools that enable biotech and pharmaceutical companies to design faster, smarter trials. A single platform that brings together essential assessments, the Aurora Suite™ consists of eleven interconnected modules that function collaboratively within a comprehensive analytics environment. Built on over 30 years of industry expertise, Aurora Analytica bridges the gap between innovation and execution’reducing costs, improving accuracy, and ultimately helping bring better therapies to patients, faster.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $389.8K
- Funding stage: Seed
- Last round: Grant (Oct 2025)
- Website: auroraanalytica.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aurora-analytica-55978 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.